Full approval is crucial for Novavax to proceed with a $175m partnership deal with Sanofi, set to commence in the 2025-2026 ...

The move comes amid HHS Secretary Robert F. Kennedy Jr.’s decision to force out the top official responsible for reviewing ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results ...

Italy's Mediobanca , Generali's top investor, said on Friday it had proposed another term for CEO Philippe Donnet at the helm ...

About Dupixent Dupixent is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available for COPD. Dupixent is intended for injection under the skin (subcutaneous ...

Ahead of his talk at TNW Conference, healthcare expert Lucien Engelen shared his vision for the future of wellbeing in the ...

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that members of its executive team will present and host 1x1 meetings at the Stifel ...

is Rs 4902 Sanofi India Ltd, incorporated in the year 1956, has its registered office in Sanofi Hse 117-B Saki Vihar Rd, L&T Business Park Powai, Mumbai, Maharashtra, 400072, 91-22-28032000 ...

Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products ... Zaltrap, developed by Sanofi and Regeneron Pharmaceuticals, will compete with Roche Holding AG’s Avastin ...

This week a remarkably interesting Federal Circuit case was decided concerning whether an asserted reference was properly shown to qualify as ...

Sanofi Consumer Healthcare India Ltd, incorporated in the year 2023, has its registered office in 3rd Floor Sanofi House CTS, 117-B L&T Business Park Powai, Mumbai, Maharashtra, 400072 ...